Jump to content

LY-2365109

From Wikipedia, the free encyclopedia
LY-2365109
Names
IUPAC name
2-[2-[4-(1,3-benzodioxol-5-yl)-2-tert-butylphenoxy]ethyl-methylamino]acetic acid
Identifiers
3D model (JSmol)
  • CC(C)(C)C1=C(C=CC(=C1)C2=CC3=C(C=C2)OCO3)OCCN(C)CC(=O)O
Properties
C22H27NO5
Molar mass 385.460 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

LY-2365109 is a glycine reuptake inhibitor. It is able to inhibit the type 1 glycine transporter.[1] This inhibition increases extracellular levels of glycine. LY-2365109 has been shown to increase the seizure threshold in mice, meaning that this drug has potential as an anticonvulsant.[2]

References

[edit]
  1. ^ Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji (2011). "Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain". PLOS ONE. 6 (6): e21322. Bibcode:2011PLoSO...621322Z. doi:10.1371/journal.pone.0021322. ISSN 1932-6203. PMC 3121759. PMID 21731704.
  2. ^ Shen, Hai-Ying; van Vliet, Erwin A.; Bright, Kerry-Ann; Hanthorn, Marissa; Lytle, Nikki K.; Gorter, Jan; Aronica, Eleonora; Boison, Detlev (December 2015). "Glycine transporter 1 is a target for the treatment of epilepsy". Neuropharmacology. 99: 554–565. doi:10.1016/j.neuropharm.2015.08.031. ISSN 1873-7064. PMC 4655139. PMID 26302655.